Peptides in Rehabilitation: A Physiotherapist’s Evidence-based Perspective
Peptides have gained attention in fitness and health for their purported benefits, including faster recovery, enhanced tissue repair, and amplified training adaptations. As a physiotherapist committed to evidence-based care, I emphasise the importance of distinguishing biological plausibility from marketing and clinical evidence. Here’s what current research reveals.
What Are Peptides?
Peptides are short chains of amino acids that act as signalling molecules in the body. The sequence and structure will determine their influence on processes such as inflammation, cell signalling, collagen production, and hormone release. Some peptides are approved therapeutics (e.g., incretin peptides in diabetes), while others are experimental or off-label for musculoskeletal recovery.
Evidence in Human Research vs Preclinical Studies
1. Collagen Peptides: The Best-Supported Category
Hydrolysed collagen peptides have clinical evidence for performance and recovery support. Studies suggests that oral supplementation can mitigate muscle damage markers after exercise and supports recovery when combined with training.
Longer-term supplementation with concurrent training improved strength recovery markers compared to placebo. This evidence is strong but modest compared to other peptides but is typically related to recovery after exercise-induced muscle damage, not injury healing.
2. Experimental Peptides: BPC-157, TB-500, and etc
Many peptides discussed in recovery circles, such as BPC-157, Thymosin Beta-4 (TB-500), CJC-1295, and GH secretagogues, are based on preclinical biology.
Studies on animals show that BPC-157 and TB-500 enhance angiogenesis, fibroblast migration, and tissue repair in rodents. Growth hormone-releasing peptides may increase systemic growth hormone and IGF-1 levels in lab animals, potentially affecting tissue growth and metabolism.
However, no high-quality randomised controlled trials demonstrate that these agents improve the healing of tendon, ligament, bone, or muscle injuries in humans. Regulatory bodies have not approved most injectable peptides for orthopedic use, and robust guidelines on dose and safety are unavailable.
Physiotherapy remains the core of injury recovery, based on well-validated rehabilitation principles: progressive loading, movement quality and motor control, and nutrition, sleep, and comorbidity management.
Peptides should be adjuncts, not replacements, for established physiotherapy.
How I Discuss Peptides with Patients
As a clinician, I:
- Explain scientific evidence – differentiate between what is supported and what is speculative.
- Stick to the basics – Focus on core rehab programming.
- Safety first – I discourage any unsupervised use of unapproved peptide injections.
Bottom line
The field of peptide therapeutics is rapidly evolving. High-quality human trials with clear functional outcomes are highly needed before physiotherapists can confidently prescribe peptides as standard treatment tools.
Peptides hold promise, but physiotherapists should rely on proven rehabilitation strategies first. Until strong human evidence supports the use of specific peptides for musculoskeletal injuries, any use should be limited to structured physiotherapy.
Any further questions or information? Feel free to bring it up as a topic of conversation with any of our physiotherapists at Sydney Physiotherapy Solutions.
